Pharma's Overachievers and Slackers in 2013

January 2, 2014 | Pharma reporter Matthew Herper offers letter grades to the 16 largest drug companies for their 2013 performance. Highlights include the ethical reforms at GlaxoSmithKline, rapid industry-wide progress in treating hepatitis C, and immunotherapy for cancer at Herper's 2013 favorite, Bristol-Myers Squibb. Forbes